<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04863027</url>
  </required_header>
  <id_info>
    <org_study_id>14.003</org_study_id>
    <nct_id>NCT04863027</nct_id>
  </id_info>
  <brief_title>Use of Dual Energy Computed Tomography in Thoracic Radiotherapy Planning.</brief_title>
  <official_title>PHASE I-II Study on the Use of Dual Energy Computed Tomography for Assessment of Lung Function in Thoracic Conventional and Stereotactic Body Radiotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Houda Bahig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Varian Medical Systems</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre hospitalier de l'Université de Montréal (CHUM)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective observational study aiming: 1) To quantify lung function using&#xD;
      perfusion dual energy computed tomography (DECT) and use this information at the time of&#xD;
      treatment planning with preferential sparing of functional lung parenchymal 2) to validate&#xD;
      results of lung function obtained using DECT with lung perfusion scintigraphy results, the&#xD;
      current standard method; 4) to compare dosimetry of whole lungs vs. functional lungs in&#xD;
      patients treated with either stereotactic body radiotherapy (SBRT) for early stage lung&#xD;
      cancer or conventional radiotherapy for locally advanced lung cancer and 5) to evaluate lung&#xD;
      function 6, 12 and 24 months post-radiotherapy with both perfusion DECT and pulmonary&#xD;
      function tests and compare radiation dose-map to functional lung-map.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lung function quantification at baseline</measure>
    <time_frame>Baseline</time_frame>
    <description>To quantify lung function using perfusion DECT and use this information at the time of treatment planning with preferential sparing of functional lung parenchyma.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radiation-induced lung function damage quantification</measure>
    <time_frame>at 12 months after radiotherapy</time_frame>
    <description>To evaluate lung function post-radiotherapy with both perfusion DECT and pulmonary function tests and compare radiation dose-map to functional lung-map.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radiation-induced lung function damage quantification</measure>
    <time_frame>at 24 months after radiotherapy</time_frame>
    <description>To evaluate lung function post-radiotherapy with both perfusion DECT and pulmonary function tests and compare radiation dose-map to functional lung-map.</description>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Lung Function Decreased</condition>
  <condition>Radiation Pneumonitis</condition>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Thoracic radiotherapy</intervention_name>
    <description>Patients will have pre-treatment and post-treatment perfusion DECT for baseline and post-treatment lung function</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with lung cancer planned for curative intent radiotherapy (conventional or&#xD;
        stereotactic)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ≥ 18 years&#xD;
&#xD;
          -  ECOG 0-2&#xD;
&#xD;
          -  Pulmonary neoplasia, confirmed histopathologically or by imaging&#xD;
&#xD;
          -  Prognosis evaluated ≥ 1 year by attending MD&#xD;
&#xD;
          -  Clinically acceptable lung capacity to undergo radiotherapy&#xD;
&#xD;
          -  Initial assessment including history, physical examination, biochemistry, PFT, chest&#xD;
             radiograph, chest and abdominal-pelvic scan, PET&#xD;
&#xD;
          -  Written consent&#xD;
&#xD;
          -  The patient must be available for treatment and monitoring. Patients registered in the&#xD;
             study should be treated in our center.&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
          -  Previous radiotherapy in the radiation field&#xD;
&#xD;
          -  Presence of any major medical condition that, in the opinion of the investigator,&#xD;
             would prevent follow-up at 6, 12 and 24 months post-radiotherapy.&#xD;
&#xD;
          -  Iodine allergy&#xD;
&#xD;
          -  Pregnancy and lactation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mom Phat</last_name>
    <email>mom.phat.chum@ssss.gouv.qc.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Silvine Benth</last_name>
    <email>silvine.benth.chum@ssss.gouv.qc.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier de l'Université de Montréal</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H2x 3E4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mom Phat</last_name>
      <email>mom.phat.chum@ssss.gouv.qc.ca</email>
    </contact>
    <contact_backup>
      <last_name>Silvine Benth</last_name>
      <email>mom.phat.chum@ssss.gouv.qc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Edith Filion, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Houda Bahig, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 29, 2021</study_first_submitted>
  <study_first_submitted_qc>April 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2021</study_first_posted>
  <last_update_submitted>April 24, 2021</last_update_submitted>
  <last_update_submitted_qc>April 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Centre hospitalier de l'Université de Montréal (CHUM)</investigator_affiliation>
    <investigator_full_name>Houda Bahig</investigator_full_name>
    <investigator_title>Radiation Oncologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Radiation Pneumonitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

